Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Maximally tolerated dose can reduce mitral regurgitation

Medication was effective in treating nearly 40 percent of heart failure patients experiencing functional mitral regurgitation (FMR) with reduced ejection fraction (HFrEF), according to a new study in JACC: Heart Failure.

Thumbnail

Ambardekar discusses findings of risk perception study, patient education

In an interview with Cardiovascular Business, the lead author of a new study discussed his team's findings in greater detail and offered recommendations based on the research.

Heart failure patients, physicians differ significantly in risk perception

Neither doctors nor patients are particularly accurate at assessing the risk of advanced heart failure (HF), according to new research. Physicians tend to overestimate the risk, while patients dramatically underestimate it.

Thumbnail

Cancer patients carry double the short-term risk of arterial thromboembolism

Patients with cancer are more than twice as likely to suffer arterial thromboembolism within six months of diagnosis as cancer-free patients, according to a new study published in the Journal of the American College of Cardiology.

Thumbnail

Birth weight strongly predictive of survival in infants with congenital heart disease

Infants with congenital heart disease (CHD) born post-term and with the most body weight have the best chance of surviving for five years, while lighter, preterm babies have poorer chances, according to new research.

Vascular Dynamics Announces FDA Approval to Initiate CALM 2 Trial for MobiusHD® System for the Treatment of Resistant Hypertension

Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today announces that the United States Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) application to initiate its pivotal trial for its MobiusHD® System for the treatment of resistant hypertension.

Study clarifies prognostic markers for STEMI patients undergoing PCI

With a goal of early risk stratification, a team of Korean researchers studied the impacts of serum biomarkers in ST-elevation myocardial infarction (STEMI) patients undergoing primary PCI. They published their findings online in PLOS One.

Study finds similar cost value of CAC testing, widespread statin treatment

When it comes to choosing whether to initiate statin treatment, similar clinical and economic consequences result if clinicians follow current guidelines or use coronary artery calcium (CAC) testing to guide that decision, according to new research.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.